CASR and congenital rubella syndrome: Recently, the CaSR was considered to be a novel target for the treatment of sepsis-induced CRS (type 5 CRS), as the CaSR mediates sepsis-induced oxidative stress, inflammation, apoptosis, and cardiorenal dysfunction [73].